Urologie最新文献

筛选
英文 中文
AUO.
IF 0.5 4区 医学
Urologie Pub Date : 2024-12-01 DOI: 10.1007/s00120-024-02483-4
{"title":"AUO.","authors":"","doi":"10.1007/s00120-024-02483-4","DOIUrl":"https://doi.org/10.1007/s00120-024-02483-4","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"63 12","pages":"1316-1317"},"PeriodicalIF":0.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Renal cell carcinoma]. [肾细胞癌]。
IF 0.5 4区 医学
Urologie Pub Date : 2024-12-01 Epub Date: 2024-12-04 DOI: 10.1007/s00120-024-02475-4
N E von Ostau, C Doehn
{"title":"[Renal cell carcinoma].","authors":"N E von Ostau, C Doehn","doi":"10.1007/s00120-024-02475-4","DOIUrl":"https://doi.org/10.1007/s00120-024-02475-4","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"63 12","pages":"1215-1216"},"PeriodicalIF":0.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitteilungen der DGU. DGU通讯。
IF 0.5 4区 医学
Urologie Pub Date : 2024-12-01 DOI: 10.1007/s00120-024-02484-3
{"title":"Mitteilungen der DGU.","authors":"","doi":"10.1007/s00120-024-02484-3","DOIUrl":"https://doi.org/10.1007/s00120-024-02484-3","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"63 12","pages":"1295-1299"},"PeriodicalIF":0.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Antibiotic prescribing practice in urological departments in Germany: results of a cross-sectional study]. [德国泌尿科抗生素处方实践:横断面研究结果]。
IF 0.5 4区 医学
Urologie Pub Date : 2024-11-19 DOI: 10.1007/s00120-024-02469-2
Winfried V Kern, Jürgen Baumann, Gesche Först, Evelyn Kramme, Michaela Steib-Bauert, Jennifer Kranz, Giuseppe Magistro, Katja de With
{"title":"[Antibiotic prescribing practice in urological departments in Germany: results of a cross-sectional study].","authors":"Winfried V Kern, Jürgen Baumann, Gesche Först, Evelyn Kramme, Michaela Steib-Bauert, Jennifer Kranz, Giuseppe Magistro, Katja de With","doi":"10.1007/s00120-024-02469-2","DOIUrl":"10.1007/s00120-024-02469-2","url":null,"abstract":"<p><strong>Background: </strong>The patterns and intensity of inpatient antibiotic prescribing vary according to medical specialty.</p><p><strong>Objectives: </strong>Analysis of recent data on antibiotic use density in hospital departments of urology in Germany.</p><p><strong>Methods: </strong>Annual surveillance data of 107 departments for the period 2022/2023 were evaluated. We used a daily dose definition adapted for adult hospitalized patients (recommended daily doses, RDD), and 100 patient days as the denominator (RDD/100).</p><p><strong>Results: </strong>The overall median antibiotic use density was 71 RDD/100 with a wide range between 15.9 and 138.7 RDD/100 but no significant differences according to hospital size. Fluoroquinolones (median 6.0 RDD/100) were prescribed as the fourth most frequent antibiotic class after broad-spectrum cephalosporins (median 16.2 RDD/100), aminopenicillin/beta-lactamase inhibitor combinations (median 10.8 RDD/100), and broad-spectrum penicillins (piperacillin-tazobactam and piperacillin) (median 8.9 RDD/100). The ratio between penicillin and cephalosporin RDD per hospital ranged from 6:94 to 98:2 (overall 52:48). The proportion of aminoglycosides (< 1%) and parenteral fosfomycin (< 0.1%) was very small. Cotrimoxazole (median 4.0 RDD/100) was less frequently prescribed than fluoroquinolones. The proportion of oral agents was 44.7% overall, with only small differences according to hospital size. Oral fosfomycin, pivmecillinam, nitrofurantoin, and nitroxoline were much less frequently prescribed than oral beta-lactams, fluoroquinolones, and cotrimoxazole.</p><p><strong>Conclusion: </strong>The overall antibiotic use density in urological hospital departments varied substantially in 2022/2023. Beta-lactam antibiotics were the most frequently used antibiotics, while fluoroquinolones (often as oral agents) continued to be prescribed with a large range similar to overall antibiotic use and independent of hospital size. Inpatient prescribing of the agents recommended and typically used for uncomplicated cystitis was rare. Penicillins and cotrimoxazole should more often be considered as the treatment option. Aminoglycosides and parenteral fosfomycin should be discussed in cases of otherwise drug-resistant pathogens.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142669231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cryopreservation of human spermatozoa or testicular tissue for fertility preservation]. [冷冻保存人类精子或睾丸组织以保留生育能力]。
IF 0.5 4区 医学
Urologie Pub Date : 2024-11-01 Epub Date: 2024-10-23 DOI: 10.1007/s00120-024-02456-7
Simone Bier, Sabine Kliesch
{"title":"[Cryopreservation of human spermatozoa or testicular tissue for fertility preservation].","authors":"Simone Bier, Sabine Kliesch","doi":"10.1007/s00120-024-02456-7","DOIUrl":"10.1007/s00120-024-02456-7","url":null,"abstract":"<p><p>Loss of reproductive capacity due to treatments for malignant or non-malignant diseases or even as a result of diseases themselves significantly impacts patients' quality of life. Cryopreservation of sperm from ejaculate is a well-established procedure for preserving the fertility of these patients and thus improving their quality of life in the long term. If cryopreservation of sperm from ejaculate is not possible, either because ejaculation cannot occur or no sperm can be found in the ejaculate, the preferred treatment option is (microsurgical) testicular sperm extraction (mTESE). Testicular sperm and ejaculated spermatozoa can be cryopreserved and later used for intracytoplasmic sperm injection (ICSI) treatment. The use of cryopreserved sperm for fertility treatment does not carry an increased risk of malformations in the offspring. If gonadotoxic therapy is necessary in pre- or early pubertal boys, the only option to preserve fertility in the long term is to cryopreserve spermatogonial stem cells from testicular tissue as part of the Androprotect© network. This is an experimental approach which has been available since 2012 across Germany and which is accompanied by intensive scientific work ( www.androprotect.de ).</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1089-1096"},"PeriodicalIF":0.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[New "conservative" treatments for Peyronie's disease-real alternatives or expensive pastime?] [佩罗尼氏病的新 "保守 "疗法--真正的替代疗法还是昂贵的消遣?]
IF 0.5 4区 医学
Urologie Pub Date : 2024-11-01 Epub Date: 2024-10-09 DOI: 10.1007/s00120-024-02453-w
Daniel Schlager, Christian Leiber-Caspers
{"title":"[New \"conservative\" treatments for Peyronie's disease-real alternatives or expensive pastime?]","authors":"Daniel Schlager, Christian Leiber-Caspers","doi":"10.1007/s00120-024-02453-w","DOIUrl":"10.1007/s00120-024-02453-w","url":null,"abstract":"<p><p>Conservative treatment of Peyronie's disease (induratio penis plastica, IPP) remains largely unsuccessful despite decades of research, as the exact disease pathogenesis remains unclear. Currently, IPP is understood as a benign, localized, progressive connective tissue disorder of the tunica albuginea, in which repetitive microtrauma triggers an inflammatory process leading to fibrosis formation. The new \"conservative\" treatment approaches focus on immune-modulatory and regenerative mechanisms, but significant therapeutic success is still lacking. Treatments such as extracorporeal shockwave therapy, platelet-rich plasma (PRP), stem cell therapy, hyaluronic acid, and botulinum toxin are promising theoretical approaches, but their efficacy is often contradictory and they remain disputed and inadequately supported by studies. Research on these therapeutic approaches is often limited by extremely high costs and the regulations for clinical studies according to the Medicines Act, albeit necessary to further evaluate their effectiveness.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1097-1102"},"PeriodicalIF":0.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142393848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AUO. AUO.
IF 0.5 4区 医学
Urologie Pub Date : 2024-11-01 DOI: 10.1007/s00120-024-02457-6
{"title":"AUO.","authors":"","doi":"10.1007/s00120-024-02457-6","DOIUrl":"10.1007/s00120-024-02457-6","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"63 11","pages":"1211-1212"},"PeriodicalIF":0.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sex-specific differences in surgical confidence: results of the Endo Workshop of the German Society of Residents in Urology 2022]. [手术信心的性别差异:2022 年德国泌尿外科住院医师协会内科研讨会的结果]。
IF 0.5 4区 医学
Urologie Pub Date : 2024-11-01 Epub Date: 2024-08-27 DOI: 10.1007/s00120-024-02429-w
Carolin Siech, Luis A Kluth, Mareen Konopka, Maximilian Reimann, Henning Plage, Isabel Lichy, Benedikt Gerdes, Jan Kasperek, Clara Humke, Phillip Marks, Margit Fisch, Pierre I Karakiewicz, Felix K H Chun, Timm Schäfer, Christian P Meyer, Julia C Kaulfuss
{"title":"[Sex-specific differences in surgical confidence: results of the Endo Workshop of the German Society of Residents in Urology 2022].","authors":"Carolin Siech, Luis A Kluth, Mareen Konopka, Maximilian Reimann, Henning Plage, Isabel Lichy, Benedikt Gerdes, Jan Kasperek, Clara Humke, Phillip Marks, Margit Fisch, Pierre I Karakiewicz, Felix K H Chun, Timm Schäfer, Christian P Meyer, Julia C Kaulfuss","doi":"10.1007/s00120-024-02429-w","DOIUrl":"10.1007/s00120-024-02429-w","url":null,"abstract":"<p><strong>Background: </strong>Simulation-based training is gaining importance in urologic residents training.</p><p><strong>Objectives: </strong>This prospective study evaluated the influence of the Endo Workshop of the German Society of Residents in Urology e. V. (GeSRU) on surgical confidence.</p><p><strong>Materials and methods: </strong>GeSRU Endo Workshop 2022 included 1 h simulation-based training sessions on stone removal using ureteroscopy (URS) and transurethral resection of the bladder (TURB). Using an online questionnaire, surgical confidence was assessed before and after the workshop. Surgical assessment relied on the global rating scale (GRS).</p><p><strong>Results: </strong>Overall, 40 residents participated: 25 (62.5%) men and 15 (37.5%) women. In URS assessment, men vs. women achieved an average of 26.6 vs. 26.1/35 points on the GRS (p = 0.7) and completed the task in 8.1 ± 1.9 vs. 9.9 ± 0.4 min (p < 0.001). In TURB assessment, men vs. women achieved an average of 26.0 vs. 27.3/35 points on the GRS (p = 0.3) and required 7.6 ± 1.9 vs. 7.7 ± 2.2 min (p = 0.9), respectively. Among participants who answered the baseline survey and the evaluation (n = 33), 16 (80%) men vs. 3 (23%) women had surgical confidence to perform URS before (p = 0.01), and 19 (95%) men vs. 7 (54%) women after the workshop (p = 0.03). Regarding the performance of TURB, 10 (50%) men vs. 7 (54%) women reported surgical confidence before (p = 0.1), and 15 (75%) men vs. 10 (77%) women after the workshop (p = 1.0). An increase in surgical confidence to perform URS and TURB was reported by 9 (45%) and 10 (50%) men and 9 (69%) and 8 (62%) women, respectively.</p><p><strong>Conclusions: </strong>Endourologic simulation-based training increases surgical confidence of both female and male residents. Despite comparable surgical outcomes, women approach URS with lower surgical confidence compared to their male counterparts.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1122-1128"},"PeriodicalIF":0.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11549232/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[S1 guideline long/post-COVID syndrome]. [S1准则长期/后COVID综合征]。
IF 0.5 4区 医学
Urologie Pub Date : 2024-11-01 Epub Date: 2024-06-17 DOI: 10.1007/s00120-024-02373-9
Christian Gogoll, Eva Peters, Volker Köllner, Rembert Koczulla
{"title":"[S1 guideline long/post-COVID syndrome].","authors":"Christian Gogoll, Eva Peters, Volker Köllner, Rembert Koczulla","doi":"10.1007/s00120-024-02373-9","DOIUrl":"10.1007/s00120-024-02373-9","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1158-1161"},"PeriodicalIF":0.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Primary retroperitoneal lymph node dissection in testicular germ cell cancer in clinical stage IIA/B-renaissance of an established treatment?] [临床 IIA/B 期睾丸生殖细胞癌的原发性腹膜后淋巴结清扫术--成熟疗法的复兴?]
IF 0.5 4区 医学
Urologie Pub Date : 2024-11-01 Epub Date: 2024-09-13 DOI: 10.1007/s00120-024-02435-y
Julian Heidenreich, Ruben Gößmann, Felix Seelemeyer, David Pfister, Pia Paffenholz, Axel Heidenreich
{"title":"[Primary retroperitoneal lymph node dissection in testicular germ cell cancer in clinical stage IIA/B-renaissance of an established treatment?]","authors":"Julian Heidenreich, Ruben Gößmann, Felix Seelemeyer, David Pfister, Pia Paffenholz, Axel Heidenreich","doi":"10.1007/s00120-024-02435-y","DOIUrl":"10.1007/s00120-024-02435-y","url":null,"abstract":"<p><strong>Background: </strong>The guideline-recommended treatment of choice for clinical stage IIA/B testicular germ cell tumors is chemotherapy with three cycles of PEB/four cycles of PE or, alternatively, radiation for seminomas. Despite their high curative efficacy, both options are associated with significant long-term toxicities. We evaluated the functional and oncological outcomes of primary retroperitoneal lymph node dissection (RPLND) as a therapeutic alternative.</p><p><strong>Patients and methods: </strong>Between 2018 and 2022, 76 patients (n = 34 seminomas, n = 42 nonseminomas) underwent primary RPLND for marker-negative clinical stage IIA/B testicular germ cell cancer. All patients underwent nerve-sparing RPLND with a unilateral or bilateral template dissection and had a follow-up ≥ 3 months. None of the patients received adjuvant chemotherapy. In 24 patients, the serum concentration of miR371a-3p was evaluated preoperatively. Follow-up was performed according to EAU guidelines.</p><p><strong>Results: </strong>Median age and median follow-up were 30.1 (17-62) years and 29.3 (3-72) months, respectively. Mean operation time, blood loss, and duration of hospitalization were 131 (105-195) min, < 150 ml, and 4.5 (3-9) days, respectively. A Clavien-Dindo IIIa complication was experienced by 8 (10.9%) patients. Antegrade ejaculation was preserved in 90.8%. A mean number of 19 (7-68) lymph nodes were dissected. The mean number of positive lymph nodes was 1.1 (1-5), and the mean diameter of positive lymph nodes was 2.4 (0.8-4.6) cm. Eleven (14.5%) patients had stage pN0 (3/34 seminomas, 8/42 nonseminomas). In 24/27 patients (88.9%) miR371 was positive, and it was negative in 4/4 with pN0 and 3/3 (100%) with teratoma. An outfield relapse was experienced by 7 patients (9.2%), who then received salvage chemotherapy.</p><p><strong>Conclusion: </strong>Primary RPLND for marker-negative clinical stage IIA/B germ cell tumors results in high cure rates without adjuvant chemotherapy and is associated with a low rate of complications if performed in experienced hands. Therefore, primary RPLND should be included in the management of these patients.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1129-1136"},"PeriodicalIF":0.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142297035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信